Allogene Therapeutics, Inc. (ALLO) has a market capitalization of $555.81M and trades at $2.28. The 52-week range is 0.86-2.8.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.6, Earnings Per Share (EPS) of $-0.87.
The stock has a beta of 0.54, operates in the Healthcare sector.
